In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease. The drug has been licensed for use in the UK but rejected by the NHS spending watchdog ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...

Donanemab – what we know about the latest Alzheimer’s drug - The drug is one of the new ‘disease modifying’ treatments for ...

MADISON, Wis.- A groundbreaking national study into the causes of Alzheimer’s and dementia has begun, led by researchers at ...

The Alzheimer’s Association has set its annual Walk to End Alzheimer’s for Saturday, Oct. 26, at Trinity United Methodist ...

Alzheimer’s disease is the leading cause of dementia in the UK. It’s a complex, challenging, and devastating condition that causes a gradual decline in a person’s cognition, including memory and ...